Medical Equipment

Heartware Delivers Australian Presentation on HVAD Implants

🕔6/15/2006 2:42:46 PM

With reference to the clinical trial currently underway for HeartWare's (ASX: HTW) HVAD left ventricular assist device, Mr McConchie commented:

Read Full Article▸

Heartware Annual General Meeting Presentation May 23, 2006

🕔5/23/2006 10:03:08 AM

HeartWare (ASX: HTW) in accordance with ASX Listing Rule 3.13.3 provides a copy of the presentations which are to be delivered today at the Company's Annual General Meeting.

Read Full Article▸

HeartWare Receives Regulatory Approval For HVAD Implants in the UK

🕔5/22/2006 11:18:26 AM

HeartWare (ASX: HTW) is pleased to announce that it has received regulatory approval from the Medicines and Healthcare Products Regulatory Agency ("MHRA") to commence implants of its HVAD circulatory assist device in the United Kingdom.

Read Full Article▸

HeartWare Ltd Offers Shareholders Discounted Shares on ASX

🕔5/19/2006 1:04:56 PM

HeartWare Limited (ASX: HTW) announced to shareholders the Share Purchase Plan dated 19 May 2006 (Plan). The Plan allows shareholders to purchase up to A$5,000 worth of ordinary shares in HeartWare Limited (Heartware or the Company) at A$1.10 per share, which is an issue price discounted to the market price of HeartWare shares on the Australian Stock Exchange (ASX) and free of brokerage or transaction costs.

Read Full Article▸

HeartWare Announce $32.5 Million Capital Raising

🕔5/10/2006 4:08:15 PM

HeartWare Limited (ASX: HTW) is pleased to announce that it has received commitments for $32.5 million from institutional and sophisticated investors in Australia and the United States.

Read Full Article▸

HeartWare Appoints COO to Florida Operations Centre

🕔4/21/2006 12:14:45 PM

HeartWare is pleased to announce the appointment of Mr Dozier Rowe as Chief Operating Officer, based at HeartWare's operations centre in Miramar, Florida.

Read Full Article▸